VSV-IFNβ-NIS

vesicular stomatitis virus expressing interferon-beta and NIS · Vyriad, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VSV-IFNβ-NIS, covering 2025-09-16 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma [Phase 2]

See pricing